Dear visitors, members and future members,
CARS welcomes you to our new home. You are welcome to share your ideas, developments and latest results of your research with your colleagues and other professionals with interest in radiopharmaceutical sciences.
The new website is a friendly environment where everyone is welcomed. Join CARS, access the member reserved area, and you will find more.
We hope that you enjoy your journey and that you will join us to enrich the community of radiopharmaceutical scientists.
Canadian Association of
Radiopharmaceutical Scientists (CARS)
- Hold scientific meetings at which members may discuss their work; such meetings need not necessarily be held on a regular basis;
- Monitor and where necessary, respond to government actions which affect either the routine preparation of radiopharmaceuticals or radiopharmaceutical research and development;
- Monitor and respond to actions of any third party which have an effect on professional practice of the members of the Association.
- Facilitate open discussions between community members
Who We Are
CARS is a professional association established with the objective of the communication of radiopharmaceutical and scientific knowledge.
Stakeholders of CARS include public at large, scientists and those with professional interest in any aspect of radiopharmaceutical sciences. CARS is facilitating an open communication between all categories of stakeholders.
Our members have access to the latest resources for professional development in radiopharmaceutical sciences.
You have access to regulatory information, latest communications in the field and updates regarding the market trends and developments in the field
CARS is welcoming you to share your ideas, news, events and topics related to radiopharmaceutical sciences on our new forum.
The space is designed to strengthen our community and to encourage open communication about your progress, challenges or new ideas.
CARS aim to provide information for educational and information only purposes.
- November 16, 2022
Nuclear Medicine Europe has reported a shortage of molybdenum-99 (Mo-99)/technetium-99m (Tc-99m) through and beyond the third week of November.Read More
- May 20, 2022
Eastern Health, Newfoundland has a vacancy for a RADIOCHEMIST (UNDER CLASSIFICATION REVIEW) PET/CT Facility Diagnostic Imaging Program – Molecular Imaging (Nuclear Medicine) Permanent, Full-Time Apply online at https://employment.easternhealth.ca Upon successfully applying for a vacancy then you will receive a confirmation email. If you do not receive this email please contact Recruitment 777-7777 ext 5-2 immediately To […]Read More
- January 26, 2022
NMEU COMMUNICATION 24 JAN 2022 Z January 26, 2022 On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that there will be a delay in the restart of the HFR Reactor that will impact the supply of Mo-99 and Lu-177 in coming weeks. The delay is due to discovery of […]Read More